Northwestern Mutual Wealth Management’s CureVac CVAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,461
Closed -$12.4K 3723
2025
Q1
$12.4K Buy
+4,461
New +$15.5K ﹤0.01% 2670
2024
Q4
Sell
-4,515
Closed -$13.3K 3666
2024
Q3
$13.3K Hold
4,515
﹤0.01% 2593
2024
Q2
$15.4K Hold
4,515
﹤0.01% 2495
2024
Q1
$13.7K Buy
4,515
+4,461
+8,261% +$15.7K ﹤0.01% 2523
2023
Q4
$227 Hold
54
﹤0.01% 3342
2023
Q3
$369 Hold
54
﹤0.01% 3140
2023
Q2
$563 Hold
54
﹤0.01% 3166
2023
Q1
$376 Hold
54
﹤0.01% 3138
2022
Q4
$326 Hold
54
﹤0.01% 3155
2022
Q3
$0 Buy
54
+19
+54% +$222 ﹤0.01% 3170
2022
Q2
$0 Hold
35
﹤0.01% 3227
2022
Q1
$1K Buy
+35
New +$699 ﹤0.01% 2979

Other funds holding CVAC

Northwestern Mutual Wealth Management's CVAC Position: Q2 2025 in Review

Northwestern Mutual Wealth Management sold out of CureVac (CVAC) in Q2 2025, closing a stake of 4,461 shares — an estimated $12.4K sold.

Northwestern Mutual Wealth Management first reported a position in CVAC in Q1 2022 and held it in 12 quarters. The position peaked at $15.4K in Q2 2024. 91 funds tracked by Wall St. Rank hold CVAC as of Q2 2025.

  • Northwestern Mutual Wealth Management reported no remaining CureVac position as of Q2 2025 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 4,461 CureVac shares in Q2 2025, an estimated $12.4K.
  • Northwestern Mutual Wealth Management first reported a position in CureVac in Q1 2022 and held it in 12 quarters.
  • Northwestern Mutual Wealth Management's CureVac position peaked at $15.4K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held CureVac as of Q2 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.